跳至主要内容
临床试验/NCT05229094
NCT05229094已完成不适用

EVA Nexus Field Observation Study. A Monocentric, Academic Field Observation Study of a Prototype of a New CE-labeled Vitrectomy Device Developed by DORC BV (The Netherlands).

Universitaire Ziekenhuizen KU Leuven1 个研究点 分布在 1 个国家目标入组 250 人开始时间: 2021年5月22日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
250
试验地点
1
主要终点
to evaluate the intra-operative safety of a new surgical device

研究概览

简要总结

determine the safety and effectiveness of the device.

详细描述

To perform a field observation study using the newly developed EVA Nexus vitrectomy device.

Patients that are scheduled for intra-ocular surgery regardless of the indication:

  • Vitrectomy surgery
  • Cataract surgery
  • Vitrectomy combined with cataract surgery

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients that are scheduled for intra-ocular surgery regardless of the indication:
  • Vitrectomy surgery
  • Cataract surgery
  • Vitrectomy combined with cataract surgery
  • In case of (combined) vitrectomy: primary or repeat vitrectomy
  • General or retrobulbar anesthesia, the latter can be combined with sedation
  • Patients aged ≥ 18 years

排除标准

  • Patients aged < 18 years

结局指标

主要结局

to evaluate the intra-operative safety of a new surgical device

时间窗: 2 days

specific adverse events that may occur during the (phaco) vitrectomy will be recorded to assess the surgical safety.

次要结局

  • To evaluate possible (S)AE that may be related to the use of the surgical platform.(2 days)
  • To evaluate the possible reduction of total surgical time(1 day)
  • To evaluate the impact of usage of the EVA NEXUS on the surgical parameters used during the procedure(2 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验